Author

A. P. Sharda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

A. M. Intlekofer· 1 shared A. N. Lane· 1 shared B. H. Segal· 1 shared C. M. James· 1 shared E. A. Repasky· 1 shared G. A. Holling· 1 shared G. Qiao· 1 shared K. H. Eng· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. M. Intlekofer

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ARS2-directed alternative splicing mediates CD28 driven T cell glycolysis and effector function

G. A. Holling, A. P. Sharda, M. M. Honikel, C. M. James, S. M. Lightman, G. Qiao, K. L. Singel, T. R. Emmons, T. Giridharan, S. Hou, A. M. Intlekofer, R. M. Higashi, T. W. M. Fan, A. N. Lane, K. H. Eng, , S. H. Olejniczak

This study shows ARS2 promotes CD28-driven T cell glycolysis and effector function through alternative splicing of Pkm2, enhancing anti-tumor immunity.

bioRxiv · May 7, 2021 · PreprintImmunology